Since the epithelial-mesenchymal transition (EMT) process is a key regulator of tumor metastasis, we performed western blotting to explore whether Rh2 has an effect on EMT-associated markers in NSCLC cells. The gene discussed is RHAG; the disease is non-small cell lung carcinoma.